FDA授予7 Hills Pharma的7HP349快速通道指定
7 Hills...
Genmab:宣布埃博拉单抗被指定为 “孤儿 “药物
Genmab...
FDA批准Servier的TIBSOVO®的sNDA申请以用于治疗急性骨髓性白血病
...
FDA授予Tonix Pharmaceuticals的TNX-2900 “孤儿药“称号
Tonix制药公司宣布，美国食品药品监督管理局（FDA）已授予TNX-2900（鼻内增效催产素）治疗Prader-Willi综合症的 "孤儿药...
FDA指定授予I-Mab公司的TJ-CD4B”孤儿药“称号
I-Mab公司宣布，美国食品药品监督管理局(FDA)已授予其新型Claudin 18.2 x 4-1BB双特异性抗体TJ-CD4B "孤儿药 "称号，用于治疗胃癌，包括胃食管交界处的癌症。TJ-CD4B是第一个临床阶段的双特异性抗体，它与表达Claudin...
FDA批准：eCoin®用于治疗尿失禁症
...
ABOUT US
CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: www.csoftintl.com